Concepedia

Kang Cheng

KC

Statistics

Publications

53

Citations

4.2K

H-Index

31

Active since

1983

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Nanjing Agricultural University

Arena Pharmaceuticals (United States)

Henan University of Technology

Kang Cheng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, pharmacology, and inflammation.

ORCID

Publications per year

1983–2025

53

Publications

53

(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G

Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan et al. · Journal of Biological Chemistry · 2005 · 651 citations · Full text

, , +17

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng et al. · The Journal of Experimental Medicine · 2005 · 363 citations · Full text

, , +17

A Nonpeptidyl Growth Hormone Secretagogue

Roy G. Smith, Kang Cheng, William R. Schoen et al. · Science · 1993 · 349 citations

, , +14

A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes.

Shinji Tamura, Thomas A. Brown, Judith H. Whipple et al. · Journal of Biological Chemistry · 1984 · 347 citations · Full text

, , +13

Role of GPR81 in lactate-mediated reduction of adipose lipolysis

Tian‐Quan Cai, Ning Ren, Lan Jin et al. · Biochemical and Biophysical Research Communications · 2008 · 296 citations

, , +13

1–5 of 53